Phorbol

Phorbol

SCHEMBL28465138

CC1=C[C@H]2[C@]3(O)[C@H](C)[C@@H](O)[C@@]4(O)[C@H]([C@@H]3C=C(CO)C[C@@]2(O)C1=O)C4(C)C.CCCCC=CCCCCCCCC(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 5/20 0.56
▸ PRKCG P05129 5/20 0.56
▸ PRKD3 O94806 4/20 0.56
▸ PRKCB P05771 4/20 0.56
▸ PRKCH P24723 4/20 0.56
▸ PRKCI P41743 4/20 0.56
▸ PRKCE Q02156 4/20 0.56
▸ PRKCQ Q04759 4/20 0.56
▸ PRKCZ Q05513 4/20 0.56
▸ PRKCD Q05655 4/20 0.56
▸ PRKD1 Q15139 4/20 0.56
▸ USP2 O75604 2/20 0.56
▸ TP53 P04637 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ NFKB1 P19838 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phorbol SCHEMBL64353 0.94 PRKCA (0.62) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL28866474 0.94 PRKCA (0.62) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL22973790 0.94 PRKCA (0.62) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL28792003 0.90 PRKCA (0.62) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL23610504 0.88 PRKCA (0.61) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL7566989 0.86 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL19466428 0.85 PRKCA (0.57) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL21462215 0.85 PRKCA (0.66) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL28352211 0.85 PRKCA (0.66) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL28498206 0.85 PRKCA (0.51) PRKCAPRKCGPRKD3PRKCBPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114651009-A Antibodies against the P.aeruginosa OprF protein, their use as medicaments and pharmaceutical compositions containing them 格勒诺布尔-阿尔卑斯大学 2022-06-21 — — CN disclosed
CN-111961142-B Preparation method of eurotium cristatum spore polysaccharide component 陕西巨子生物技术有限公司 2022-03-22 — — CN disclosed
CN-113543798-A Methods and compositions for treating skin disorders 范德比尔特大学 2021-10-22 — — CN disclosed
CN-111759853-B Pharmaceutical composition and application thereof 陕西巨子生物技术有限公司 2021-10-22 — — CN disclosed
CN-111961142-A Preparation method of eurotium cristatum spore polysaccharide component 陕西巨子生物技术有限公司 2020-11-20 — — CN disclosed
CN-111759853-A Pharmaceutical composition and application thereof 陕西巨子生物技术有限公司 2020-10-13 — — CN disclosed
Send feedback